JPT is a key player in the world of peptides. They create special tools like peptide microarrays that help map out immune responses. They also offer services that speed up the creation of new ...
Songji Biotech Enterprise Co., Ltd. (SGBE) has announced the commercial launch of standardized 1,000-Dalton marine collagen peptides, scientifically validated for anti-aging efficacy through a ...
Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through ...
Synthetic peptides, generally less than 20 amino acids in length, are essential reagents for a wide range of studies and one of the fundamental tools of proteomics researchers. Applications include ...
BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai. The facility expands the company’s peptide synthesis ...
The Peptide-Builder is designed for peptide chemists who want to make high-quality peptides quickly and easily at a laboratory scale. Peptides are synthesized sequentially and fully automated either ...
Cyclic peptides offer enhanced stability and bioavailability, but precise cyclization strategies and specialized synthetic techniques are required to maintain their biological activity. A recent ...
Ottawa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The global chemical synthesis peptide drugs market size is calculated at USD 2.74 billion in 2025 and is expected to reach around USD 4.82 billion by 2034, ...
In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...
Therapeutic peptides constitute an unusual drug category. Although most therapeutic peptides are synthetic, their molecular weights are well above those of small-molecule drugs, but well below those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results